FI67217C - Foerfarande foer framstaellning av farmakologiskt vaerdefulla 1-brom-3-(4-hydroxibensoyl)-indolizinderivat - Google Patents

Foerfarande foer framstaellning av farmakologiskt vaerdefulla 1-brom-3-(4-hydroxibensoyl)-indolizinderivat Download PDF

Info

Publication number
FI67217C
FI67217C FI802165A FI802165A FI67217C FI 67217 C FI67217 C FI 67217C FI 802165 A FI802165 A FI 802165A FI 802165 A FI802165 A FI 802165A FI 67217 C FI67217 C FI 67217C
Authority
FI
Finland
Prior art keywords
bromo
indolizine
benzoyl
hydroxy
phenyl
Prior art date
Application number
FI802165A
Other languages
English (en)
Finnish (fi)
Other versions
FI802165A (fi
FI67217B (fi
Inventor
Gilbert Rosseels
Pierre Nokin
Original Assignee
Labaz Sanofi Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Labaz Sanofi Nv filed Critical Labaz Sanofi Nv
Publication of FI802165A publication Critical patent/FI802165A/fi
Publication of FI67217B publication Critical patent/FI67217B/fi
Application granted granted Critical
Publication of FI67217C publication Critical patent/FI67217C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI802165A 1979-07-06 1980-07-07 Foerfarande foer framstaellning av farmakologiskt vaerdefulla 1-brom-3-(4-hydroxibensoyl)-indolizinderivat FI67217C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB7923599 1979-07-06
GB7923599 1979-07-06

Publications (3)

Publication Number Publication Date
FI802165A FI802165A (fi) 1981-01-07
FI67217B FI67217B (fi) 1984-10-31
FI67217C true FI67217C (fi) 1985-02-11

Family

ID=10506339

Family Applications (1)

Application Number Title Priority Date Filing Date
FI802165A FI67217C (fi) 1979-07-06 1980-07-07 Foerfarande foer framstaellning av farmakologiskt vaerdefulla 1-brom-3-(4-hydroxibensoyl)-indolizinderivat

Country Status (24)

Country Link
US (1) US4400387A (pl)
EP (1) EP0022762B1 (pl)
JP (1) JPS5618979A (pl)
AR (1) AR225314A1 (pl)
AT (1) AT375078B (pl)
AU (1) AU529725B2 (pl)
CA (1) CA1153379A (pl)
DD (1) DD151940A5 (pl)
DE (1) DE3060097D1 (pl)
DK (1) DK146962C (pl)
ES (1) ES493139A0 (pl)
FI (1) FI67217C (pl)
GR (1) GR69280B (pl)
HU (1) HU182151B (pl)
IE (1) IE49994B1 (pl)
IN (1) IN151594B (pl)
NO (1) NO153496C (pl)
NZ (1) NZ193926A (pl)
OA (1) OA06563A (pl)
PL (1) PL125597B1 (pl)
PT (1) PT71424A (pl)
SU (1) SU993817A3 (pl)
YU (1) YU171880A (pl)
ZA (1) ZA803434B (pl)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6103702A (en) * 1999-05-24 2000-08-15 Board Of Trustees Of The University Of Illinois Use of adenosine deaminase inhibitors to treat systemic inflammatory response syndrome
AU6234000A (en) * 1999-07-22 2001-02-13 Supergen, Inc. Methods for treating autoimmune diseases
FR2805460A1 (fr) 2000-02-25 2001-08-31 Oreal Compositions de teinture des fibres keratiniques contenant des derives d'indolizine cationiques et procede de teinture
FR2838123B1 (fr) * 2002-04-04 2005-06-10 Sanofi Synthelabo Nouveaux derives d'indolozine-1,2,3 substituee, inhibiteurs selectifs du b-fgf
JP4048166B2 (ja) * 2002-11-18 2008-02-13 三井製糖株式会社 血糖値上昇抑制剤及び体脂肪蓄積抑制剤並びに食用材料
FR2859997B1 (fr) * 2003-09-18 2006-02-03 Sanofi Synthelabo Nouveaux derives d'indolizine 1,2,3,6,7,8 substituee, inhibiteurs des fgfs, leur procede de preparation et les compositions pharmaceutiques les contenant.
AR051780A1 (es) * 2004-11-29 2007-02-07 Japan Tobacco Inc Compuestos en anillo fusionados que contienen nitrogeno y utilizacion de los mismos
FR2896247B1 (fr) 2006-01-13 2008-02-29 Sanofi Aventis Sa Composes dimeres agonistes des recepteurs des fgfs (fgfrs), leur procede de preparation et leur application en therapeutique
RU2529868C2 (ru) * 2009-03-31 2014-10-10 Кисcеи Фармасьютикал Ко., Лтд. Производное индолизина и его применение в медицинских целях
US20100261666A1 (en) * 2009-04-14 2010-10-14 The Board Of Trustees Of The University Of Illinois Compositions and methods for the treatment of myocardial dysfunction associated with sirs or sepsis
JP5906191B2 (ja) * 2010-09-29 2016-04-20 キッセイ薬品工業株式会社 （アザ）インドリジン誘導体及びその医薬用途
NZ741318A (en) * 2015-09-10 2019-03-29 Jiangsu Atom Bioscience And Pharmaceutical Co Ltd Compound for treating or preventing hyperuricemia or gout
CN108084186B (zh) 2016-11-16 2021-06-25 江苏新元素医药科技有限公司 Urat1抑制剂及其应用
WO2018090921A1 (zh) 2016-11-16 2018-05-24 江苏新元素医药科技有限公司 Urat1抑制剂及其应用
CN108727267B (zh) * 2017-05-26 2022-05-13 江苏新元素医药科技有限公司 一类urat1抑制剂及其应用
WO2018214961A1 (zh) * 2017-05-26 2018-11-29 江苏新元素医药科技有限公司 促尿酸排泄的urat1抑制剂
CN117586272A (zh) 2018-01-19 2024-02-23 苏州信诺维医药科技股份有限公司 杂环化合物、制备方法及其在医药上的应用
CN110283167A (zh) * 2018-11-14 2019-09-27 贵州省中国科学院天然产物化学重点实验室 一种抗心率失常药物布托普洛嗪的制备方法
WO2022169974A1 (en) 2021-02-05 2022-08-11 Nexys Therapeutics, Inc. Inhibitors of urat1 and pharmaceutical uses thereof
WO2023221078A1 (en) * 2022-05-20 2023-11-23 Jiangsu Atom Bioscience And Pharmaceutical Co., Ltd. Solid forms of a compound for treating or preventing hyperuricemia or gout

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU430639A1 (ru) 1972-06-05 1978-02-28 Московский Ордена Ленина И Ордена Трудового Красного Знамени Государственный Университет Им.М.В.Ломоносова Способ получени 1-пиридилиндолизинов
FI61030C (fi) 1976-02-19 1982-05-10 Sanofi Sa Foerfarande foer framstaellning av terapeutiskt verkande 2-substituerade-1- eller 3-benzoyl-indolizinderivat
GB1518443A (en) * 1976-02-19 1978-07-19 Labaz Indolizine derivatives and process for preparing the same

Also Published As

Publication number Publication date
CA1153379A (en) 1983-09-06
AR225314A1 (es) 1982-03-15
AT375078B (de) 1984-06-25
DK291180A (da) 1981-01-07
IE801349L (en) 1981-01-06
HU182151B (en) 1983-12-28
NO802015L (no) 1981-01-07
NO153496C (no) 1986-05-14
ZA803434B (en) 1981-05-27
US4400387A (en) 1983-08-23
PT71424A (en) 1980-07-01
GR69280B (pl) 1982-05-13
FI802165A (fi) 1981-01-07
DK146962C (da) 1984-08-06
YU171880A (en) 1983-10-31
FI67217B (fi) 1984-10-31
PL125597B1 (en) 1983-05-31
NZ193926A (en) 1984-05-31
EP0022762A1 (fr) 1981-01-21
IE49994B1 (en) 1986-01-22
PL225479A1 (pl) 1981-10-30
AU5948780A (en) 1981-01-15
DD151940A5 (de) 1981-11-11
DE3060097D1 (en) 1982-01-28
NO153496B (no) 1985-12-23
SU993817A3 (ru) 1983-01-30
JPS5618979A (en) 1981-02-23
ES8105710A1 (es) 1981-06-16
ES493139A0 (es) 1981-06-16
OA06563A (fr) 1981-07-31
ATA354380A (de) 1983-11-15
IN151594B (pl) 1983-06-04
AU529725B2 (en) 1983-06-16
DK146962B (da) 1984-02-27
EP0022762B1 (fr) 1981-11-25

Similar Documents

Publication Publication Date Title
FI67217C (fi) Foerfarande foer framstaellning av farmakologiskt vaerdefulla 1-brom-3-(4-hydroxibensoyl)-indolizinderivat
FI75347C (fi) Foerfarande foer framstaellning av farmakologiskt vaerdefulla furo-(3,4-c)-pyridinderivat.
De Sarro et al. 5H-[1, 2, 4] Oxadiazolo [5, 4-d][1, 5] benzothiazepines as anticonvulsant agents in DBA/2 mice
FR2543829A1 (fr) Preparations therapeutiques a base de nouveaux derives de la furo-(3,4-c)-pyridine
US5223503A (en) 6-substituted pyrido[2,3-d]pyrimidines as antineoplastic agents
JPH01283285A (ja) 新規なアセチレン、シアノ及びアレンアリステロマイシン／アデノシン誘導体類
GB2119789A (en) Olefinic benzimidazoles
PT84923B (pt) Processo para a preparacao de derivados de 1-(hidroxiestiril)-5h-2,3-benzodiazepina e de composicoes farmaceuticas que os contem
JPS63154658A (ja) ３−［ω−（３，５−ジ−ｔ−ブチル−４−ヒドロキシフェニル）アルカノイル］ピロール類、それらのデオキシ類似体およびそれらの治療用途
US4058559A (en) 4-Aroyl-substituted phenoxy acetic acids
EP0594149A2 (en) Condensed pyrazole derivatives, method of manufacturing the same, and androgen inhibitor
US4166819A (en) 4-Aroyl substituted phenoxy methylene-5-tetrazoles
Coats et al. Comparative analysis of the cytotoxicity of substituted [phenylglyoxal bis (4-methyl-3-thiosemicarbazone] copper (II) chelates
HUT59096A (en) Process for producing indenoindol compounds and pharmaceutical compositions containing them
CN106188068A (zh) 3,6‑二芳基‑[1,2,4]三氮唑并[4,3‑b]哒嗪类化合物及用途
JPS6344577A (ja) ピリミジン誘導体
US4806535A (en) Imidazolylphenyl and 1,2,4-triazolylphenyl benzopyridazinone and pyridopyridazinone compounds and their use for increasing cardiatonic contractility
US4075215A (en) Thieno-pyridine derivatives
EP3950064A1 (en) Thymine nucleobase-based triazolopyrimidines and production method therefor
NZ204608A (en) Indolizine derivatives and pharmaceutical and veterinary compositions
GB2051812A (en) Indolizine derivatives
Floyd et al. Prostaglandins and congeners. 22. Synthesis of 11-substituted derivatives of 11-deoxyprostaglandins E1 and E2. Potential bronchodilators
US4829066A (en) Pyridooxazinone-pyridazinone and pyrazolone compounds, cardiotonic compositions including the same, and their use
US3879414A (en) Enol betaines of benzimidazoles
US3520873A (en) Inosine 2',3',acetals

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: S.A. LABAZ - SANOFI N.V.